ArticleBritish journal of cancer2014

Long-term survival of advanced triple-negative breast cancers with a dose-intense cyclophosphamide/anthracycline neoadjuvant regimen.

S Giacchetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.